Chemical penetration enhancers: a patent review

被引:74
|
作者
Ahad, Abdul [1 ]
Aqil, Mohammed [1 ]
Kohli, Kanchan [1 ]
Chaudhary, Hema [1 ]
Sultana, Yasmin [1 ]
Mujeeb, Mohammed [1 ]
Talegaonkar, Sushama [1 ]
机构
[1] Hamdard Univ, Fac Pharm, Dept Pharmaceut, New Delhi 110062, India
关键词
penetration enhancers; percutaneous absorption enhancement; sorption promoters; transdermal drug delivery; transdermal patent; VITRO PERCUTANEOUS-ABSORPTION; TRANSDERMAL DELIVERY; IN-VITRO; HUMAN-SKIN; PERMEATION ENHANCERS; PROPRANOLOL HYDROCHLORIDE; PROPYLENE-GLYCOL; FATTY-ACIDS; RAT; 5-FLUOROURACIL;
D O I
10.1517/13543770902989983
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Ever since transdermal drug delivery came into existence, it has offered great promises, although most of them are yet to be fulfilled owing to some intrinsic restrictions of the transdermal route. On the positive side, transdermal drug delivery systems present advantages including non-invasiveness, prolonged therapeutic effect, reduced side effects, improved bioavailability, better patient compliance and easy termination of drug therapy. The greatest hindrance in the percutaneous delivery is the obstruction property of the stratum corneum, the outermost layer of the skin, in addition to usual problems such as skin binding, skin metabolism, cutaneous toxicity and prolonged lag times. Objective: This paper reviews investigations on the feasibility and application of penetration enhancers as described in recent patents, which help in the selection of a suitable sorption promoter(s) for enhanced delivery of medicaments through the skin. Method: The patents granted under various categories of penetration enhancers have been discussed including fatty acids, terpenes, fatty alcohol, pyrrolidone, sulfoxides, laurocapram, surface active agents, amides, amines, lecithin, polyols, quaternary ammonium compounds, silicones, alkanoates and so on. Conclusion: Scores of promising chemicals have been harnessed for their skin permeation promoting capacity as mentioned earlier. In future, many more chemicals and putative enhancers are likely be documented and patented.
引用
收藏
页码:969 / 988
页数:20
相关论文
共 50 条
  • [1] Chemical penetration enhancers
    Lopes, Luciana B.
    Garcia, Maria Teresa J.
    Bentley, Maria Vitoria L. B.
    THERAPEUTIC DELIVERY, 2015, 6 (09) : 1053 - 1061
  • [2] Novel Penetration Enhancers for Skin Applications: A Review
    Parhi, Rabinarayan
    Suresh, Padilama
    Mondal, Sumant
    Kumar, Posa Mahesh
    CURRENT DRUG DELIVERY, 2012, 9 (02) : 219 - 230
  • [3] Chemical Penetration Enhancers for Transdermal Drug Delivery Systems
    Pathan, Inayat Bashir
    Setty, C. Mallikarjuna
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2009, 8 (02) : 173 - 179
  • [4] Chemical Penetration Enhancers in Topical Application and Their Synergistic Combination
    Spaglova, Miroslava
    Cuchorova, Maria
    Bartonikova, Kamila
    Simunkova, Veronika
    CHEMICKE LISTY, 2020, 114 (08): : 530 - 536
  • [5] Penetration enhancers
    Williams, AC
    Barry, BW
    ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (05) : 603 - 618
  • [6] Penetration enhancers
    Williams, Adrian C.
    Barry, Brian W.
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 : 128 - 137
  • [7] Current Development of Chemical Penetration Enhancers for Transdermal Insulin Delivery
    Sugumar, Vaisnevee
    Hayyan, Maan
    Madhavan, Priya
    Wong, Won Fen
    Looi, Chung Yeng
    BIOMEDICINES, 2023, 11 (03)
  • [8] Design principles of chemical penetration enhancers for transdermal drug delivery
    Karande, P
    Jain, A
    Ergun, K
    Kispersky, V
    Mitragotri, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (13) : 4688 - 4693
  • [9] CPE-DB: An Open Database of Chemical Penetration Enhancers
    Vasyuchenko, Ekaterina P.
    Orekhov, Philipp S.
    Armeev, Grigoriy A.
    Bozdaganyan, Marine E.
    PHARMACEUTICS, 2021, 13 (01) : 1 - 14
  • [10] In vitro percutaneous absorption enhancement of granisetron by chemical penetration enhancers
    Zhao, Nanxi
    Cun, Dongmei
    Li, Wei
    Ma, Xu
    Sun, Lin
    Xi, Honglei
    Li, Li
    Fang, Liang
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (04) : 561 - 568